EUVIMEDEUVIMED entdecken
Open Access

Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment

Xuxuan Gao iD, Feng Zhang, Jiafeng Zhang, Yu Ma, Yiting Deng iD, Jiaying Chen, Yueran Ren, Huidi Wang, Boxin Zhao iD, Yan He iD, Jia Yin iD

Journal of the American Heart Association · 06.05.2025 · 14 (9)

DOI: 10.1161/jaha.124.038862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 06.05.2025. Verfasst von Xuxuan Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Ursodeoxycholic Acid, Gastrointestinal Microbiome, Cognition. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Poststroke cognitive impairment (PSCI) is a common residual disability after stroke, often underestimated and underdiagnosed. We previously found that ursodeoxycholic acid (UDCA), a host‐microbiota cometabolite, ameliorates brain damage in stroke mice. Based on these findings, we aimed to evaluate the predictive value of UDCA for PSCI risk in a prospective cohort study. Methods and Results We recruited 202 patients with mild acute ischemic stroke and 63 patients with symptomatic large‐artery atherosclerotic stenosis as the modeling and external validation cohorts, respectively. Mice were subjected to transient middle cerebral artery occlusion, and cognitive function was assessed using the Morris water maze test. Patients with mild acute ischemic stroke who developed PSCI exhibited significant alterations in gut microbiota and plasma bile acid profiles during the acute stroke phase, including a notable reduction in UDCA level. Through feature selection and machine learning, we constructed a predictive model for PSCI incorporating plasma UDCA level, the relative abundance of Clostridia, Bacilli, and Bacteroides , as well as age, educational level, and the presence of moderate to severe white matter lesions. This model exhibited robust predictive performance in both internal (area under the curve, 0.904 [95% CI, 0.808–1.000]) and external (area under the curve, 0.838 [95% CI, 0.742–0.934]) validations. Animal studies in mice also showed reduced UDCA levels in plasma and brain tissue following stroke. UDCA administration improved cognitive function in stroke mice by reducing hippocampal microglial activation and neuronal apoptosis.

Conclusions

Our findings indicate that UDCA has potential as a biomarker for predicting PSCI risk and plays a neuroprotective role in the progression of PSCI. This suggests that early identification and intervention targeting UDCA could represent a promising strategy for the prevention and treatment of PSCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionUrsodeoxycholic AcidGastrointestinal MicrobiomeCognitionIschemic StrokeAnimalsMaleHumansFemaleMiceAgedProspective StudiesDisease Models, AnimalMiddle AgedMice, Inbred C57BLBehavior, Animal

Stichwörter der Autor:innen

bile acidcognitive impairmentgut microbiotastrokeursodeoxycholic acid

Substanzen

Ursodeoxycholic Acid

Autor:innen und Institutionen

  • Department of Neurology, Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of China.
  • Department of Neurosurgery, Huzhou Central Hospital Zhejiang University School of Medicine Huzhou Zhejiang People's Republic of China.
  • Comprehensive Medical Treatment Ward, Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of China.
  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital Southern Medical University Guangzhou Guangdong People's Republic of China.
  • Department of Pharmacy, Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of China.
  • Clinical Pharmacy Center Nanfang Hospital, Southern Medical University Guangzhou Guangdong People's Republic of China.

ORCID-Profile: Xuxuan Gao, Yiting Deng, Boxin Zhao, Yan He, Jia Yin

Zitieren

APA

Gao, X., Zhang, F., Zhang, J., Ma, Y., Deng, Y., Chen, J., Ren, Y., Wang, H., Zhao, B., He, Y., & Yin, J. (2025). Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment. Journal of the American Heart Association, 14(9). https://doi.org/10.1161/jaha.124.038862

Vancouver

Gao X, Zhang F, Zhang J, Ma Y, Deng Y, Chen J, et al. Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment. Journal of the American Heart Association. 2025;14(9). doi:10.1161/jaha.124.038862

BibTeX
@article{Gao2025,
  author = {Gao, Xuxuan and Zhang, Feng and Zhang, Jiafeng and Ma, Yu and Deng, Yiting and Chen, Jiaying and Ren, Yueran and Wang, Huidi and Zhao, Boxin and He, Yan and Yin, Jia},
  title = {Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {9},
  doi = {10.1161/jaha.124.038862}
}
Kostenlos starten →